FDA NDC Directory · JSON-LD · Markdown

TEVIMBRA

NDC 72579-125 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION, CONCENTRATE

Generic nametislelizumab-jsgr
Labeler / ManufacturerBeOne Medicines USA, Inc.
Marketing categoryBiologic License Application · App BLA761232
Dosage form / routeINJECTION, SOLUTION, CONCENTRATE · INTRAVENOUS
Active ingredientsTISLELIZUMAB (10 mg/mL)
Marketing started20260713
Package count1

External sources

Source: openFDA. Public-domain (CC0).